SCHEMBL8771948

SCHEMBL8771948

O=C(c1ccccc1)c1ccc([S+]([O-])c2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
SRD5A2 P31213 2/20 0.56
L3MBTL1 Q9Y468 3/20 0.50
ATM Q13315 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
RAB9A P51151 5/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
MAPK13 O15264 1/20 0.48
MAPK12 P53778 1/20 0.48
MAPK11 Q15759 1/20 0.48
MAPK14 Q16539 1/20 0.48
NPC1 O15118 4/20 0.47
HPGD P15428 3/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1576927 0.98 ALDH1A1 (0.61) ALDH1A1SRD5A2L3MBTL1ATMTDP1
SCHEMBL7940723 0.90 MEN1 (0.63) ALDH1A1SRD5A2L3MBTL1ATMTDP1
SCHEMBL27432711 0.89 ALDH1A1 (0.57) ALDH1A1SRD5A2L3MBTL1ATMTDP1
SCHEMBL21679503 0.89 AKR1C3 (0.51) ALDH1A1SRD5A2L3MBTL1ATMTDP1
SCHEMBL7935392 0.89 LMNA (0.51) ALDH1A1SRD5A2L3MBTL1ATMTDP1
SCHEMBL28741311 0.86 ATM (0.61) ALDH1A1SRD5A2L3MBTL1ATMTDP1
SCHEMBL11322836 0.85 CES2 (0.65) ALDH1A1SRD5A2L3MBTL1RAB9ACA2
SCHEMBL506129 0.85 TSHR (0.54) ALDH1A1SRD5A2TDP1HPGDCA12
SCHEMBL3212763 0.83 ALDH1A1 (0.64) ALDH1A1SRD5A2L3MBTL1ATMTDP1
SCHEMBL3200877 0.83 ALDH1A1 (0.64) ALDH1A1SRD5A2L3MBTL1ATMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9469604-B2 Method of manufacturing sulfonium salt TOYO GOSEI CO., LTD. (JP) 2016-10-18 US claimed
EP-3480205-B1 SULFONIUM SALT, PHOTOACID GENERATOR, PHOTOCURABLE COMPOSITION, AND CURED PRODUCT THEREOF SAN APRO LTD (JP) 2022-04-13 EP disclosed
CN-108884110-B Sulfonium salt, photoacid generator, photocurable composition, and cured product thereof 三亚普罗股份有限公司 2021-09-14 CN disclosed
US-10995082-B2 Cationic photoinitiator and preparation method and use thereof CHANGZHOU TRONLY NEW ELECTRONIC MATERIALS CO., LTD. (CN) 2021-05-04 US disclosed
US-10683266-B2 Sulfonium salt, photoacid generator, photocurable composition, and cured product thereof SAN APRO LTD. (JP) 2020-06-16 US disclosed
US-20190300476-A1 SULFONIUM SALT, PHOTOACID GENERATOR, PHOTOCURABLE COMPOSITION, AND CURED PRODUCT THEREOF SAN-APRO LTD. (JP) 2019-10-03 US disclosed
US-20190218199-A1 NOVEL CATIONIC PHOTOINITIATOR AND PREPARATION METHOD AND USE THEREOF CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD. (CN) 2019-07-18 US disclosed
EP-3480205-A1 SULFONIUM SALT, PHOTOACID GENERATOR, PHOTOCURABLE COMPOSITION, AND CURED PRODUCT THEREOF San-Apro Ltd. (JP) 2019-05-08 EP disclosed
CN-108884110-A Sulfonium salt, photoacid generator, Photocurable composition and its solidified body 三亚普罗股份有限公司 2018-11-23 CN disclosed
US-9469604-B2 Method of manufacturing sulfonium salt TOYO GOSEI CO., LTD. (JP) 2016-10-18 US disclosed
US-20160068477-A1 METHOD OF MANUFACTURING SULTONIUM SALT TOYO GOSEI CO., LTD. (JP) 2016-03-10 US disclosed
EP-0629613-B1 Novel onium salt, photopolymerization initiator, energy ray-curing composition containing the initiator, and cured product NIPPON KAYAKU KK (JP) 1997-10-15 EP disclosed
US-5534557-A COATINGS NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1996-07-09 US disclosed
US-5502083-A SULFONIUM CATALYST NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1996-03-26 US disclosed
EP-0629613-A2 Novel onium salt, photopolymerization initiator, energy ray-curing composition containing the initiator, and cured product NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1994-12-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10995082-B2 Cationic photoinitiator and preparation method and use thereof SLC11A2, SLC7A1, PPOX ALDH1A1 3153/4885SRD5A2 3603/4885L3MBTL1 3858/4885
US-20190300476-A1 SULFONIUM SALT, PHOTOACID GENERATOR, PHOTOCURABLE COMPOSITION, AND CURED PRODUCT THEREOF ASIC1, TST, SPIN2B ALDH1A1 821/4885SRD5A2 3839/4885L3MBTL1 4655/4885
US-10683266-B2 Sulfonium salt, photoacid generator, photocurable composition, and cured product thereof ASIC1, TST, SPIN2B ALDH1A1 821/4885SRD5A2 3839/4885L3MBTL1 4655/4885
US-20160068477-A1 METHOD OF MANUFACTURING SULTONIUM SALT STS, SULT1A1, ARSA ALDH1A1 1425/4885SRD5A2 718/4885L3MBTL1 4511/4885
US-20190218199-A1 NOVEL CATIONIC PHOTOINITIATOR AND PREPARATION METHOD AND USE THEREOF SLC11A2, SLC7A1, PPOX ALDH1A1 2798/4885SRD5A2 3423/4885L3MBTL1 4242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.